Navigation Links
NIAID awards contracts to search for protein markers of disease
Date:10/9/2008

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded two five-year contracts to establish Clinical Proteomics Centers for Infectious Diseases and Biodefense. The contracts were awarded to the University of Texas Medical Branch (UTMB), Galveston, and to the Canadian firm Caprion Proteomics, Montreal. Researchers at the centers will analyze human blood and other tissue samples from completed or ongoing clinical studies with the aim of discovering proteins that could serve as biomarkers of infectious disease.

A biomarker is a measurable biological substance that acts as an indicator of either health or disease. One biomarker test now used by doctors is the prostate-specific antigen (PSA) blood test for prostate cancer screening. Elevated levels of PSA protein in the blood may signal the presence of cancerous cells in the prostate gland.

Scientists at the new NIAID-funded centers will look for proteins produced either by disease-causing agents or by the immune system in response to infection. "Identifying specific biomarkers that are present in infected people--but absent in uninfected people--would give researchers new leads in understanding how microbes cause disease and how the body reacts to those microbes," says Maureen Beanan, Ph.D., a program officer in NIAID's Division of Microbiology and Infectious Diseases. This, in turn, could guide development of diagnostics, therapies or vaccines, she adds.

The first two diseases to be studied at the new centers will be dengue fever, a viral illness spread by mosquitoes, and brucellosis, a bacterial disease that can cause severe influenza-like symptoms. Once discovered and characterized, any candidate biomarkers found by the centers' scientists will be made freely available to the research community at large for further development.

The centers also will encourage clinical infectious disease researchers from other institutions to submit clinical samples to be assessed for the presence of potential biomarker proteins, notes Dr. Beanan. This service will be provided at no charge to the requestors.

The five-year contract to UTMB is estimated to be up to $10.9 million. The five-year contract to Caprion Proteomics is estimated to be up to $12.9 million.

Besides the new clinical proteomics centers, NIAID has established numerous research resources in the areas of bioinformatics, functional and structural genomics, and gene and protein sequencing. Together, these resources are assisting scientists to better understand interactions between disease-causing organisms and the human immune response. For more information about these resources, see http://www3.niaid.nih.gov/topics/pathogenGenomics.


'/>"/>

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Related medicine news :

1. NIAID funds $51M contract to create comprehensive model of immune responses
2. NIAID strengthens and expands Vaccine and Treatment Evaluation Units
3. NIAID scientists identify new cellular receptor for HIV
4. NIAID to convene HIV Vaccine Summit
5. NIAID describes research priorities to fight drug-resistant tuberculosis
6. NIAID to advance B-cell approach to HIV vaccines
7. NIAID creates HIV vaccine discovery branch
8. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
9. Good Clinical Practice Journal Awards: Winners Announced
10. NIH awards $10.8M to Columbia to study connection between diabetes and heart disease
11. NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever ... Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation ... as home to some of the world’s leading providers of cereal and other breakfast ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Those who ... with these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, ... Marne, Michigan, has released tools for healthy coping following a traumatic event. , Trauma ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
(Date:6/23/2016)... ITASCA, Ill. , June 23, 2016  In a startling ... states are failing their residents by lacking a comprehensive, proven plan ... , a definitive ranking of how states are tackling the ... rating to only four states – Kentucky , ... and Vermont . Of the 28 failing states, ...
(Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: